BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 10370699)

  • 1. Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer.
    Hanazaki K; Mochizuki Y; Machida T; Yokoyama S; Sodeyama H; Sode Y; Wakabayashi M; Kawamura N; Miyazaki T
    Hepatogastroenterology; 1999; 46(26):1238-43. PubMed ID: 10370699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative chemotherapy in elderly patients with advanced gastric cancer.
    Hanazaki K; Mochizuki Y; Igarashi J; Yokoyama S; Sodeyama H; Sode Y; Wakabayashi M; Kawamura N; Miyazaki T; Amano J
    Hepatogastroenterology; 2000; 47(36):1761-4. PubMed ID: 11149051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
    Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
    Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of surgery in the patients with stage I and II primary gastric lymphoma.
    Takahashi I; Maehara Y; Koga T; Sumiyoshi Y; Oshiro T; Baba H; Kohnoe S; Okamura T; Uike N; Matsusaka T; Kume K; Sugimachi K
    Hepatogastroenterology; 2003; 50(51):877-82. PubMed ID: 12828109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy in a unique population of patients with gastric cancer undergoing surgery.
    Uslu A; Karaca C; Nart A; Adagülü H; Aykas A; Gürkan A; Dogan M
    Hepatogastroenterology; 2004; 51(58):1245-8. PubMed ID: 15239288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upper abdominal stop-flow perfusion as a neo and adjuvant hypoxic regional chemotherapy for resectable gastric carcinoma. A prospective randomized clinical trial.
    Lygidakis NJ; Sgourakis G; Aphinives P
    Hepatogastroenterology; 1999; 46(27):2035-8. PubMed ID: 10430393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palliative gastrectomy for advanced gastric cancer.
    Hanazaki K; Sodeyama H; Mochizuki Y; Igarashi J; Yokoyama S; Sode Y; Wakabayashi M; Kawamura N; Miyazaki T
    Hepatogastroenterology; 2001; 48(37):285-9. PubMed ID: 11268986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastric carcinoma: curative resection and adjuvant chemotherapy.
    Carrillo Hernández JF; Ernesto de Obaldía Castillo G; Ramírez Ortega C; Frías Mendivil M; Pardo M
    Arch Med Res; 1994; 25(1):29-35. PubMed ID: 8019111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of extended lymphadenectomy in the noncurative gastrectomy for advanced gastric cancer.
    Hanazaki K; Sodeyama H; Mochizuki Y; Machida T; Yokoyama S; Sode Y; Wakabayashi M; Kawamura N; Miyazaki T; Amano J
    Hepatogastroenterology; 1999; 46(28):2677-82. PubMed ID: 10522064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraoperative radiotherapy combined with adjuvant chemoradiotherapy for locally advanced gastric adenocarcinoma.
    Fu S; Lu JJ; Zhang Q; Yang Z; Peng L; Xiong F
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1488-94. PubMed ID: 18538489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.
    Nashimoto A; Nakajima T; Furukawa H; Kitamura M; Kinoshita T; Yamamura Y; Sasako M; Kunii Y; Motohashi H; Yamamoto S;
    J Clin Oncol; 2003 Jun; 21(12):2282-7. PubMed ID: 12805327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute.
    Cho BC; Jeung HC; Choi HJ; Rha SY; Hyung WJ; Cheong JH; Noh SH; Chung HC
    J Surg Oncol; 2007 May; 95(6):461-8. PubMed ID: 17192913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma.
    Koo DH; Lee JL; Kim TW; Chang HM; Ryu MH; Yook JH; Oh ST; Kim BS; Lee JS; Kang YK
    Eur J Surg Oncol; 2007 Sep; 33(7):843-8. PubMed ID: 17207959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination 5-fluoruracil/cisplatinum versus 5-fluoruracil/leucovorin adjuvant chemotherapy efficacy for R0 gastric resection in locally invasive gastric cancer.
    Yamada S; Ritchim P; Charkrabandhu T; Jongraksat W
    J Med Assoc Thai; 2012 Dec; 95(12):1517-23. PubMed ID: 23390781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-fluorouracil, mitomycin-C, and polysaccharide-K adjuvant chemoimmunotherapy for locally advanced gastric cancer: the prognostic significance of frequent perineural invasion.
    Choi JH; Kim YB; Lim HY; Park JS; Kim HC; Cho YK; Han SW; Kim MW; Joo HJ
    Hepatogastroenterology; 2007; 54(73):290-7. PubMed ID: 17419278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stage IV gastric cancer patient who underwent palliative gastrectomy showing complete response to induction therapy with methotrexate plus 5-fluorouracil and secondary treatment with oral TS-1].
    Hiramatsu K; Mizukami Y; Momiyama M; Suzuki M; Niimi K; Nagashima T
    Gan To Kagaku Ryoho; 2005 Aug; 32(8):1163-6. PubMed ID: 16121921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of advanced gastric carcinoma with liver metastasis with no recurrence and long survival by means of surgery and postoperative chemotherapy].
    Koyasaki N; Matsumura A; Kamata T; Kanno M
    Gan To Kagaku Ryoho; 2002 Apr; 29(4):611-4. PubMed ID: 11977549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of immunochemo-surgery for gastric carcinoma.
    Kim JP; Yu HJ; Lee JH
    Hepatogastroenterology; 2001; 48(41):1227-30. PubMed ID: 11677936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative clinical study of adjuvant postoperative chemotherapy (5-FU, Tegafur, 5-FU + MMC) in curatively resected cases of gastric cancer. Study Group on 5-FU Oral Adjuvant Chemotherapy in Gastric Cancer].
    Nakajima T; Miwa K; Ohmori Y; Sakabe T; Fujii M; Kajitani T
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1161-8. PubMed ID: 8751804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
    Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG
    Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.